Back to Search
PIERRE LAVERTU, MD
MD
Otolaryngology Physician
NPI: 1659301943IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
35-049034(OH)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
OTHER
Class of 1976
Research & Publications (20)
P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
PMID 11801963·Laryngoscope·2001
3-trial
Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma.
PMID 19672875·Head Neck·2010
8-other
Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?
PMID 19358250·Laryngoscope·2009
8-other
Giant intrathyroid parathyroid adenoma: a preoperative and intraoperative diagnostic challenge.
PMID 19291619·Ear Nose Throat J·2009
5-case
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.
PMID 19265494·Thyroid·2009
3-trial
Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
PMID 18704968·Head Neck·2008
8-other
Molecular classification of thyroid nodules by cytology.
PMID 18094649·Laryngoscope·2008
4-observational
Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
PMID 16505425·J Clin Oncol·2006
8-other
Xanthogranulomatous sialadenitis: a case report and literature review.
PMID 16075862·Ear Nose Throat J·2005
5-case
Competition between antiferromagnetism and superconductivity in high-Tc cuprates.
PMID 15904166·Phys Rev Lett·2005
8-other
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.
PMID 15538570·Cancer Chemother Pharmacol·2005
3-trial
Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
PMID 12966502·Head Neck·2003
8-other
Recurrence rates after selective neck dissection in the N0 irradiated neck.
PMID 11886346·Arch Otolaryngol Head Neck Surg·2002
8-other
Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy.
PMID 11870186·J Clin Oncol·2002
8-other
Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma.
PMID 11753963·Cancer·2001
8-other
The use and misuse of neck dissection for head and neck cancer.
PMID 11442259·J Am Coll Surg·2001
8-other
Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?
PMID 11335904·Cancer·2001
8-other
Surgical salvage after chemoradiation of head and neck cancer: complications and outcomes.
PMID 11123873·Curr Oncol Rep·2001
4-observational
Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study.
PMID 11031409·Arch Otolaryngol Head Neck Surg·2000
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11100 EUCLID AVE
CLEVELAND, OH 44106 - Phone
- (216) 844-6000
Quick Facts
- NPI
- 1659301943
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 50
- Publications
- 20
Are you this provider?
Claim Your Profile